title: Oral valganciclovir treatment for congenital cytomegalovirus infection.
authors.affiliation: Departments of PediatricsMicrobiologyOtolaryngologyObstetrics, Fukushima Medical University School of Medicine, FukushimaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan. ima@fmu.ac.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Imamura
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Suzutani
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ogawa
authors.forename: Kimisato
authors.initials: K
authors.lastname: Asano
authors.forename: Mika
authors.initials: M
authors.lastname: Nomoto
authors.forename: Takamichi
authors.initials: T
authors.lastname: Matsui
authors.forename: Nobuo
authors.initials: N
authors.lastname: Momoi
authors.forename: Kazufumi
authors.initials: K
authors.lastname: Ikuta
authors.forename: Naoki
authors.initials: N
authors.lastname: Inoue
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Hosoya
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001299:Audiometry; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy*; D018450:Disease Progression; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D034381:Hearing Loss / Q000821:virology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015997:Neonatal Screening; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D000077562:Valganciclovir
chemical_list: D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir